GlassScriptPhysician profile
Joseph Gass
NPI 1467456251
$8,048.98
in general payments reported to CMS, 2019-2025
48 companies · $519 in 2025
The $519 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $163 · 2021: $695 · 2022: $2,117 · 2023: $966 · 2024: $2,732 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,917 · Travel and Lodging: $1,288 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.66 |
| Travel and Lodging | $1,287.74 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,222.64 | 2021-2024 | Axonics, Bulkamid |
| Aspira Women'S Health INC | $805.00 | 2020-2024 | Ova1 |
| Abbvie INC. | $469.73 | 2019-2025 | |
| Biogen, INC. | $454.43 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $299.17 | 2019-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $220.38 | 2019-2022 | |
| Shield Therapeutics INC | $198.08 | 2024-2025 | |
| Amgen INC. | $197.46 | 2019-2024 | Prolia, Evenity |
| Allergan, INC. | $191.35 | 2019 | |
| Novo Nordisk INC | $165.68 | 2019-2024 | Wegovy, Saxenda |
| Gynesonics, INC. | $153.01 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $151.89 | 2023-2024 | Myfembree |
| Organon LLC | $148.50 | 2022-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $140.95 | 2021-2023 | |
| Channel Medsystems, INC. | $106.41 | 2023 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.